Author:
Karampitsakos Theodoros,Spagnolo Paolo,Tzouvelekis Argyris
Reference18 articles.
1. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury;Kumar;Front Immunol.,2020
2. Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial;Karampitsakos;Clin Microbiol Infect.,2023
3. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects;Crystal;Ann Intern Med.,1976
4. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis;Idiopathic Pulmonary Fibrosis Clinical Research;The New England J Med.,2012
5. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study;Scott;Lancet Respir Med.,2019